will compounded semaglutide be banned The FDA's Decision to Ban Compounds: What You Need to Know FDA Ban on Compounded GLP-1

Serious Side Effects Rare but serious risks may include: Severe pancreatitis (persistent severe abdominal pain) Gallbladder problems Severe dehydration Kidney injury Allergic reactions Possible thyroid tumors (based on animal studies) Seek immediate medical attention if there is: Severe, ongoing abdominal pain Swelling of the face or throat Difficulty breathing Signs of severe dehydration Drug Interactions Semaglutide may interact with other medications

I highly doubt it

The researchers wrote that although a causal link between the drugs and these problems cannot be established, they hypothesize that rapid lowering of high blood glucose may be at the root of the eye problems

The GLP-1 average weight loss per month guide shows timeline expectations

President, Lilly Cardiometabolic Health and President, Lilly USA, said Lilly plans to planning to bolster its marketing of Mounjaro and launch efforts to boost demand for Zepbound, including a direct-to-consumer marketing campaign, in earnest in mid-November